The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) – associations with symptoms.
Jonsjo MA et al. (2020) The role of low-grade inflammation […]
Research Papers
Increased neutrophil apoptosis in chronic fatigue syndrome.
Increased neutrophil apoptosis in chronic fatigue syndrome. Read More »
Kennedy G ,,, et al. (2004) Increased neutrophil apoptosis in
Epstein-Barr virus induced gene-2 upregulation identifies a particular subtype of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis.
Kerr JR. (2019) Epstein-Barr virus induced gene-2 upregulation identifies a
Inflammation correlates with symptoms in chronic fatigue syndrome.
Inflammation correlates with symptoms in chronic fatigue syndrome. Read More »
Komaroff AL. (2017) Inflammation correlates with symptoms in chronic fatigue
Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Lande A et al. (2020) Human Leukocyte Antigen alleles associated
Chronic Low-Grade Inflammation in Metabolic Disorders: Relevance for Behavioral Symptoms.
Lasselin J and Capuron L . (2014) Chronic Low-Grade Inflammation
Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
Lidbury BA et al. (2017) Activin B is a novel
Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
Eaton N et al. (2018) Rituximab impedes natural killer cell
A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome.
Eaton-Fitch N et al. (2019) A systematic review of natural
The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP 2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Eaton-Fitch N et al. (2021)The effect of IL-2 stimulation and
Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.
Eaton-Fitch N et al . (2022) Impaired TRPM3-dependent calcium influx
Investigating the role of TGF-B and fatigue in Chronic Fatigue Syndrome.
Investigating the role of TGF-B and fatigue in Chronic Fatigue Syndrome. Read More »
Dibnah B et al. (2019) Investigating the role of TGF-B
Decreased Expression of the CD57 Molecule in T Lymphocytes of Patients with Chronic Fatigue Syndrome.
Espinosa P and Urra JM (2019) Decreased Expression of the
Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Freitag H et al . (2021) Autoantibodies to Vasoregulative G-Protein-Coupled
Plasma cytokines in women with chronic fatigue syndrome.
Plasma cytokines in women with chronic fatigue syndrome. Read More »
Fletcher MA et al. (2009) Plasma cytokines in women with
Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidyl peptidase IV/CD26.
Fletcher MA et al. (2010) Biomarkers in chronic fatigue syndrome:
Searching for Serum Antibodies to Neuronal Proteins in Patients With Myalgic Encephalopathy/Chronic Fatigue Syndrome.
Giannoccaro MP et al. (2019) Searching for Serum Antibodies to
Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
Giloteaux L et al. (2020) Cytokine profiling of extracellular vesicles
Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
G�mez-Mora E et al. (2020) Impact of Long-Term Cryopreservation on
MCP-1 is Increased in Patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls.
Groven N et al. (2020) MCP-1 is Increased in Patients